A Look At Benzinga Pro's Most-Searched Tickers For June 25, 2019

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

1. Minerva Neurosciences, Inc. NERV shares were down 2.87% to $5.76. The stock rose 40% on Monday after it announced its Phase 2B trial for the clinical trial of seltorexant achieved its primary and key secondary objectives.
2. Palatin Technologies Inc. PTN shares were down 10% to $1.08. Shares spiked 50% Monday after the FDA approved NDA for Vyleesi drug for the treatment of premenopausal women with acquired HSDD.
3. VivoPower International VVPR shares were down 23% to $1.57. On Monday, shares rose 34% after the company announced new international parties have engaged in the company’s solar portfolio sale.
4. BioPharmX Corp BPMX shares were up 10.8% to 94 cents after the company reported its Phase 2B trial of BPX-04 for papulopustular rosacea met both primary and secondary endpoints and was well tolerated.
5. Immunic, Inc. IMUX shares were down 26% to $13.20. On Monday, shares rose 90% following news the company to present previously unpublsihed data regarding the lead program, IMU-838, at the GI inflammatory diseases summit.
6. Beyond Meat, Inc. BYND shares were up 3.5% to $145.72. The stock continued to see volatility after hitting new highs the previous week.
7. Caesars Entertainment Corp CZR shares were up 2.4% to $11.72.
8. Avinger, Inc. AVGR shares were down 9.8% to $3.32. The stock has seen volatility over the last two sessions.
9. Krystal Biotech, Inc. KRYS shares were up 11.4% to $45.90 after Guggenheim reiterated a Buy rating and raised the price target from $48 to $75.
10. Allergan plc AGN shares were up 26.7% to $164. The company announced it will be acquired by AbbVie for a $188.24 per share in cash and stock.